Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
53
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

Colin Reisner1 Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA;2 AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
,
James Pearle3 California Research Medical Group, Inc., Fullerton, CA, USA
,
Edward M Kerwin4 Clinical Research Institute of Southern Oregon, Medford, OR, USA
,
Earl St Rose1 Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA
&
Patrick Darken1 Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA
Pages 1965-1977 | Published online: 19 Jun 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.